Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

被引:95
|
作者
Stevens, Kristen N. [1 ]
Vachon, Celine M. [1 ]
Lee, Adam M. [2 ]
Slager, Susan [1 ]
Lesnick, Timothy [1 ]
Olswold, Curtis [1 ]
Fasching, Peter A. [4 ]
Miron, Penelope [5 ]
Eccles, Diana [6 ]
Carpenter, Jane E. [7 ]
Godwin, Andrew K. [8 ,9 ]
Ambrosone, Christine [10 ]
Winqvist, Robert [11 ]
Brauch, Hiltrud [15 ,16 ,17 ,18 ,19 ,20 ]
Schmidt, Marjanka K. [21 ,22 ]
Cox, Angela [24 ]
Cross, Simon S. [25 ]
Sawyer, Elinor [26 ]
Hartmann, Arndt [29 ]
Beckmann, Matthias W. [32 ]
Schulz-Wendtland, Ruediger [30 ]
Ekici, Arif B. [31 ]
Tapper, William J. [6 ]
Gerty, Susan M. [6 ]
Durcan, Lorraine [6 ]
Graham, Nikki [6 ]
Hein, Rebecca [33 ]
Nickels, Stephan [33 ]
Flesch-Janys, Dieter [35 ]
Heinz, Judith [35 ]
Sinn, Hans-Peter [34 ]
Konstantopoulou, Irene [36 ]
Fostira, Florentia [36 ]
Pectasides, Dimitrios [37 ]
Dimopoulos, Athanasios M. [38 ]
Fountzilas, George [39 ]
Clarke, Christine L. [7 ]
Balleine, Rosemary [40 ]
Olson, Janet E. [1 ]
Fredericksen, Zachary [1 ]
Diasio, Robert B. [2 ]
Pathak, Harsh [41 ]
Ross, Eric [42 ]
Weaver, JoEllen [41 ]
Ruediger, Thomas [43 ]
Forsti, Asta [44 ,45 ]
Duennebier, Thomas
Ademuyiwa, Foluso [11 ]
Kulkarni, Swati [12 ]
Pylkaes, Katri [13 ]
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pharmacol, Rochester, MN 55905 USA
[3] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Univ Southampton, Fac Med, Southampton Univ Hosp, NHS Trust, Southampton SO9 5NH, Hants, England
[7] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia
[8] Univ Kansas, Med Ctr, Dept Pathol, Lawrence, KS 66045 USA
[9] Univ Kansas, Med Ctr, Lab Med, Lawrence, KS 66045 USA
[10] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA
[11] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[12] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA
[13] Univ Oulu, Oulu Univ Hosp, Canc Genet Lab, Dept Clin Genet & Bioctr Oulu, Oulu, Finland
[14] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland
[15] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Gene Environm Interact & Breast Canc Germany GENI, D-7000 Stuttgart, Germany
[16] Univ Tubingen, D-72074 Tubingen, Germany
[17] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, Bonn, Germany
[18] Univ Bonn, Inst Pathol, Fac Med, D-5300 Bonn, Germany
[19] German Social Accid Insurance IPA, Inst Prevent & Occupat Med, Bochum, Germany
[20] Deutsch Krebsforschungszentrum, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[21] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Expt Therapy & Mol Pathol, Amsterdam, Netherlands
[22] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Epidemiol MKS, Amsterdam, Netherlands
[23] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin SV, Amsterdam, Netherlands
[24] Univ Sheffield, Fac Med Dent & Hlth, Dept Oncol, Inst Canc Studies, Sheffield, S Yorkshire, England
[25] Univ Sheffield, Fac Med Dent & Hlth, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England
[26] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res Comprehens, Biomed Res Ctr, London, England
[27] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England
[28] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
[29] Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, D-8520 Erlangen, Germany
[30] Univ Erlangen Nurnberg, Inst Diagnost Radiol, Univ Hosp Erlangen, D-8520 Erlangen, Germany
[31] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany
[32] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, Univ Hosp Erlangen, Breast Ctr Franconia, D-8520 Erlangen, Germany
[33] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany
[34] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[35] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany
[36] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab IRRP, Athens, Greece
[37] Hippokrateion Hosp, Oncol Sect, Dept Internal Med, Athens, Greece
[38] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[39] Aristotle Univ Thessaloniki, Dept Med Oncol, Papageorgiou Hosp, Thessaloniki, Greece
[40] Westmead Hosp, Dept Translat Oncol, Western Sydney Local Hlth Network, Westmead, NSW 2145, Australia
[41] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[42] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
[43] Stadt Klinikum Karlsruhe, Inst Pathol, Karlsruhe, Germany
[44] Deutsch Krebsforschungszentrum, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[45] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[46] Evangel Kliniken Bonn gGmbH, Johanniter Krankenhaus, Dept Internal Med, Bonn, Germany
[47] Univ Hosp Gasthuisberg, Multidisciplinary Breast Ctr, B-3000 Louvain, Belgium
[48] VIB, Vesalius Res Ctr, Louvain, Belgium
[49] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium
[50] Univ Melbourne, Canc Epidemiol Ctr, Canc Council Victoria, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会; 芬兰科学院; 英国医学研究理事会;
关键词
GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; MUTATION CARRIERS; RISK-FACTORS; BRCA1; VARIANTS; ALLELES; COMPLEX; PROTEINS; SUBTYPES;
D O I
10.1158/0008-5472.CAN-11-1266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancers are an aggressive subtype of breast cancer with poor survival, but there remains little known about the etiologic factors that promote its initiation and development. Commonly inherited breast cancer risk factors identified through genome-wide association studies display heterogeneity of effect among breast cancer subtypes as defined by the status of estrogen and progesterone receptors. In the Triple Negative Breast Cancer Consortium (TNBCC), 22 common breast cancer susceptibility variants were investigated in 2,980 Caucasian women with triple-negative breast cancer and 4,978 healthy controls. We identified six single-nucleotide polymorphisms, including rs2046210 (ESR1), rs12662670 (ESR1), rs3803662 (TOX3), rs999737 (RAD51L1), rs8170 (19p13.1), and rs8100241 (19p13.1), significantly associated with the risk of triple-negative breast cancer. Together, our results provide convincing evidence of genetic susceptibility for triple-negative breast cancer. Cancer Res; 71(19); 6240-9. (C)2011 AACR.
引用
收藏
页码:6240 / 6249
页数:10
相关论文
共 50 条
  • [41] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [42] Triple-negative breast cancer fly
    Ferreira, Jorge
    LAB ANIMAL, 2024, 53 (08) : 191 - 191
  • [43] MicroRNAs in triple-negative breast cancer
    Koleckova, M.
    Janikova, M.
    Kolar, Z.
    NEOPLASMA, 2018, 65 (01) : 1 - 13
  • [44] Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
    Adkins, Farrell C.
    Gonzalez-Angulo, Ana Maria
    Lei, Xiudong
    Hernandez-Aya, Leonel F.
    Litton, Jennifer K.
    Meric-Bernstam, Funda
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S158 - S158
  • [45] Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
    Farrell C. Adkins
    Ana Maria Gonzalez-Angulo
    Xiudong Lei
    Leonel F. Hernandez-Aya
    Elizabeth A. Mittendorf
    Jennifer K. Litton
    Jamie Wagner
    Kelly K. Hunt
    Wendy A. Woodward
    Funda Meric-Bernstam
    Annals of Surgical Oncology, 2011, 18
  • [46] Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
    Adkins, Farrell C.
    Gonzalez-Angulo, Ana Maria
    Lei, Xiudong
    Hernandez-Aya, Leonel F.
    Mittendorf, Elizabeth A.
    Litton, Jennifer K.
    Wagner, Jamie
    Hunt, Kelly K.
    Woodward, Wendy A.
    Meric-Bernstam, Funda
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (11) : 3164 - 3173
  • [47] Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression
    Romero, Pierre
    Benhamo, Vanessa
    Deniziaut, Gabrielle
    Fuhrmann, Laetitia
    Berger, Frederique
    Manie, Elodie
    Bhalshankar, Jaydutt
    Vacher, Sophie
    Laurent, Cecile
    Marangoni, Elisabetta
    Gruel, Nadege
    MacGrogan, Gaetan
    Rouzier, Roman
    Delattre, Olivier
    Popova, Tatiana
    Reyal, Fabien
    Stern, Marc-Henri
    Stoppa-Lyonnet, Dominique
    Marchio, Caterina
    Bieche, Ivan
    Vincent-Salomon, Anne
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (10): : 2378 - 2391
  • [48] Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
    Purrington, Kristen S.
    Slager, Susan
    Eccles, Diana
    Yannoukakos, Drakoulis
    Fasching, Peter A.
    Miron, Penelope
    Carpenter, Jane
    Chang-Claude, Jenny
    Martin, Nicholas G.
    Montgomery, Grant W.
    Kristensen, Vessela
    Anton-Culver, Hoda
    Goodfellow, Paul
    Tapper, William J.
    Rafiq, Sajjad
    Gerty, Susan M.
    Durcan, Lorraine
    Konstantopoulou, Irene
    Fostira, Florentia
    Vratimos, Athanassios
    Apostolou, Paraskevi
    Konstanta, Irene
    Kotoula, Vassiliki
    Lakis, Sotiris
    Dimopoulos, Meletios A.
    Skarlos, Dimosthenis
    Pectasides, Dimitrios
    Fountzilas, George
    Beckmann, Matthias W.
    Hein, Alexander
    Ruebner, Matthias
    Ekici, Arif B.
    Hartmann, Arndt
    Schulz-Wendtland, Ruediger
    Renner, Stefan P.
    Janni, Wolfgang
    Rack, Brigitte
    Scholz, Christoph
    Neugebauer, Julia
    Andergassen, Ulrich
    Lux, Michael P.
    Haeberle, Lothar
    Clarke, Christine
    Pathmanathan, Nirmala
    Rudolph, Anja
    Flesch-Janys, Dieter
    Nickels, Stefan
    Olson, Janet E.
    Ingle, James N.
    Olswold, Curtis
    CARCINOGENESIS, 2014, 35 (05) : 1012 - 1019
  • [49] Secreted CLU is associated with the initiation of triple-negative breast cancer
    Zhang, Danfang
    Sun, Baocun
    Zhao, Xiulan
    Cui, Yanfen
    Xu, Shaoyan
    Dong, Xueyi
    Zhao, Jianmin
    Meng, Jie
    Jia, Xiaohua
    Chi, Jiadong
    CANCER BIOLOGY & THERAPY, 2012, 13 (05) : 321 - 329
  • [50] Triple-negative Breast Cancer is not Associated with Increased Nodal Metastases
    Gangi, A.
    Mirocha, J.
    Leong, T.
    Giuliano, A. E.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S57 - S57